|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/08 | (2006.01) |
| C07D 487/08 | (2006.01) | ||
| A61K 31/529 | (2006.01) | ||
| A61P 7/00 | (2006.01) |
| (11) | Patento numeris | 3392249 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18174593.6 |
| Europos patento paraiškos padavimo data | 2015-01-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201461933942 P | 2014-01-31 | US | |
| 201462058293 P | 2014-10-01 | US |
| (72) |
CORTE, James R. , US
DE LUCCA, Indawati , US
FANG, Tianan , US
YANG, Wu , US
WANG, Yufeng , US
DILGER, Andrew K. , US
PABBISETTY, Kumar Balashanmuga , US
EWING, William R. , US
ZHU, Yeheng , US
WEXLER, Ruth R. , US
PINTO, Donald J. P. , US
ORWAT, Michael J. , US
SMITH, Leon M. II , US
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | MACROCYCLES WITH HETEROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS |
| MACROCYCLES WITH HETEROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS |